Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos

Detalhes bibliográficos
Ano de defesa: 2016
Autor(a) principal: Quaresma, Marielle Pires
Orientador(a): Souza, Emmanuel Prata de
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://www.repositorio.ufc.br/handle/riufc/60372
Resumo: Intestinal Mucositis is a higher adverse effects of treatment with 5-fluorouracil. In this context, probiotics are widely used to protect gastrointestinal disorders. Here we report the effect Probiotil® composed by probiotics Lactobacillus acidophilus and Bifidobacterium lactis, and Probiatop® composed by Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus rhamnosus and Bifidobacterium lactis in intestinal mucositis induced by 5-FU. Such methodology was used male Swiss mice (25-30g), treated with a single intraperitoneal dose by 5-FU (450 mg / kg ip), and controls with(saline and DMSO). In the Probiotics groups was administrated Probiotil® or Probiatop® 1h, 24h and 48h (V.O.) after induction by 5-FU . 72h after 5-FU administration, mice was euthanized. Segments from Duodenum, jejunum and ileum were removed for evaluations: measurement of villous / crypt ratio; Histological scores; concentration of glutathione (GSH), malondialdehyde (MDA), proinflammatory cytokines (TNF-α and IL-6) activity and myeloperoxidase (MPO). In addition, we investigated the weight analysis, leukogram, gastric emptying and intestinal transit of animals. Our results showed that Probiatop® decreased the weight loss induced by 5-FU, but Probiotil® did not change weight loss. The probiotics had no effect on leukopenia but both probiotics were capable of reverting changes in three intestinal segments (duodenum, jejunum and ileum), such as increased GSH levels (except the ileum), decreased MDA levels, indicating a reduction oxidative stress. The probiotics decreased TNF-α and IL-6 levels, neutrophils infiltration, reducing the inflammatory response. The relationship villus / crypt was reversed, demonstrating intestinal mucosal protection. Probiotics did not show a significant reversal of histological scores. The delayed gastric emptying was reversed by Probiatop® but not by Probiotil®. However, there was no effect of probiotics on the intestinal transit changes. In conclusion, Probiotil® and Probiatop® protected the intestinal mucosa from antioxidant and anti-inflammatory activities. However, only Probiatop® reversed gastric emptying.
id UFC-7_cd8eda960197290c71821f67fe48c50d
oai_identifier_str oai:repositorio.ufc.br:riufc/60372
network_acronym_str UFC-7
network_name_str Repositório Institucional da Universidade Federal do Ceará (UFC)
repository_id_str
spelling Quaresma, Marielle PiresSoares, Pedro Marcos GomesSouza, Emmanuel Prata de2021-09-10T12:08:29Z2021-09-10T12:08:29Z2016QUARESMA, Marielle Pires. Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos. 2016. 86 f. Dissertação (Mestrado em Ciências Morfofuncionais ) - Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, 2016.http://www.repositorio.ufc.br/handle/riufc/60372Intestinal Mucositis is a higher adverse effects of treatment with 5-fluorouracil. In this context, probiotics are widely used to protect gastrointestinal disorders. Here we report the effect Probiotil® composed by probiotics Lactobacillus acidophilus and Bifidobacterium lactis, and Probiatop® composed by Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus rhamnosus and Bifidobacterium lactis in intestinal mucositis induced by 5-FU. Such methodology was used male Swiss mice (25-30g), treated with a single intraperitoneal dose by 5-FU (450 mg / kg ip), and controls with(saline and DMSO). In the Probiotics groups was administrated Probiotil® or Probiatop® 1h, 24h and 48h (V.O.) after induction by 5-FU . 72h after 5-FU administration, mice was euthanized. Segments from Duodenum, jejunum and ileum were removed for evaluations: measurement of villous / crypt ratio; Histological scores; concentration of glutathione (GSH), malondialdehyde (MDA), proinflammatory cytokines (TNF-α and IL-6) activity and myeloperoxidase (MPO). In addition, we investigated the weight analysis, leukogram, gastric emptying and intestinal transit of animals. Our results showed that Probiatop® decreased the weight loss induced by 5-FU, but Probiotil® did not change weight loss. The probiotics had no effect on leukopenia but both probiotics were capable of reverting changes in three intestinal segments (duodenum, jejunum and ileum), such as increased GSH levels (except the ileum), decreased MDA levels, indicating a reduction oxidative stress. The probiotics decreased TNF-α and IL-6 levels, neutrophils infiltration, reducing the inflammatory response. The relationship villus / crypt was reversed, demonstrating intestinal mucosal protection. Probiotics did not show a significant reversal of histological scores. The delayed gastric emptying was reversed by Probiatop® but not by Probiotil®. However, there was no effect of probiotics on the intestinal transit changes. In conclusion, Probiotil® and Probiatop® protected the intestinal mucosa from antioxidant and anti-inflammatory activities. However, only Probiatop® reversed gastric emptying.A mucosite intestinal é um dos efeitos adversos mais incidentes do tratamento com 5-Fluorouracil. Nesse contexto, microrganismos probióticos são cada vez mais utilizados como alternativas para proteção da mucosa gastrintestinal deste efeito colateral e distúrbios associados. Este estudo teve como objetivo avaliar o efeito de Probiotil® composto pelos probióticos Lactobacillus acidophilus e Bifidobacterium lactis, e Probiatop® composto por Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus rhamnosus e Bifidobacterium lactis na mucosite intestinal experimental induzida por 5-FU. Para a execução do protocolo utilizou-se camundongos machos Swiss (25-30g) que foram tratados com dose única intraperitoneal de 5-FU (450mg/Kg i.p.), com exceção dos controles (Salina e DMSO). Os grupos probióticos foram tratados com o Probiotil® ou Probiatop® 1h, 24h e 48h (v.o.) após a indução por 5-FU, sendo eutanasiados após 72h da indução de mucosite. Segmentos do duodeno, jejuno e íleo foram obtidos para as seguintes avaliações: mensuração da relação vilo/cripta; escores histológicos; dosagem de glutationa (GSH), malondialdeído (MDA), citocinas pró-inflamatórias (TNF-α e IL-6) e atividade da enzima mieloperoxidase (MPO). Além disso, avaliou-se a análise ponderal, leucograma, esvaziamento gástrico e trânsito intestinal dos animais. Observou-se que Probiatop® diminuiu a perda de peso induzida por 5-FU, mas este efeito não foi demonstrado pelo Probiotil®. Os probióticos não apresentaram efeito sobre a leucopenia induzida por 5-FU. Ambos os probióticos foram capazes de reverter alterações induzidas pelo tratamento com 5-FU nos três segmentos intestinais (duodeno, jejuno e íleo), como por exemplo, aumentaram os níveis de GSH (com exceção do íleo) e diminuíram de MDA, indicando uma redução de estresse oxidativo; diminuíram os níveis das citocinas TNF-α e IL-6, e o acúmulo de neutrófilos, amenizando a resposta inflamatória; reverteram o desarranjo da relação vilo/cripta demonstrando uma proteção da mucosa intestinal. Na análise histopatológica, os probióticos não apresentaram uma reversão significativa dos escores histológicos. O retardo do esvaziamento gástrico foi revertido pelo Probiatop®, mas não pelo Probiotil®. No entanto, não foi observado efeito dos probióticos sobre as alterações de trânsito intestinal. Diante do exposto, conclui-se que Probiotil® e Probiatop® protegem a mucosa intestinal a partir de atividades antioxidantes e anti-inflamatórias. No entanto somente Probiatop® reverteu o esvaziamento gástrico.MucositeFluoruracilaProbióticosLactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisporreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccessLICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.ufc.br/bitstream/riufc/60372/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52ORIGINAL2016_dis_mpquaresma.pdf2016_dis_mpquaresma.pdfapplication/pdf2426573http://repositorio.ufc.br/bitstream/riufc/60372/1/2016_dis_mpquaresma.pdf92b5a033489cdddbeb4809932bdf1a83MD51riufc/603722021-09-10 09:08:30.027oai:repositorio.ufc.br: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Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2021-09-10T12:08:30Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false
dc.title.pt_BR.fl_str_mv Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
title Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
spellingShingle Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
Quaresma, Marielle Pires
Mucosite
Fluoruracila
Probióticos
title_short Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
title_full Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
title_fullStr Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
title_full_unstemmed Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
title_sort Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos
author Quaresma, Marielle Pires
author_facet Quaresma, Marielle Pires
author_role author
dc.contributor.co-advisor.none.fl_str_mv Soares, Pedro Marcos Gomes
dc.contributor.author.fl_str_mv Quaresma, Marielle Pires
dc.contributor.advisor1.fl_str_mv Souza, Emmanuel Prata de
contributor_str_mv Souza, Emmanuel Prata de
dc.subject.por.fl_str_mv Mucosite
Fluoruracila
Probióticos
topic Mucosite
Fluoruracila
Probióticos
description Intestinal Mucositis is a higher adverse effects of treatment with 5-fluorouracil. In this context, probiotics are widely used to protect gastrointestinal disorders. Here we report the effect Probiotil® composed by probiotics Lactobacillus acidophilus and Bifidobacterium lactis, and Probiatop® composed by Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus rhamnosus and Bifidobacterium lactis in intestinal mucositis induced by 5-FU. Such methodology was used male Swiss mice (25-30g), treated with a single intraperitoneal dose by 5-FU (450 mg / kg ip), and controls with(saline and DMSO). In the Probiotics groups was administrated Probiotil® or Probiatop® 1h, 24h and 48h (V.O.) after induction by 5-FU . 72h after 5-FU administration, mice was euthanized. Segments from Duodenum, jejunum and ileum were removed for evaluations: measurement of villous / crypt ratio; Histological scores; concentration of glutathione (GSH), malondialdehyde (MDA), proinflammatory cytokines (TNF-α and IL-6) activity and myeloperoxidase (MPO). In addition, we investigated the weight analysis, leukogram, gastric emptying and intestinal transit of animals. Our results showed that Probiatop® decreased the weight loss induced by 5-FU, but Probiotil® did not change weight loss. The probiotics had no effect on leukopenia but both probiotics were capable of reverting changes in three intestinal segments (duodenum, jejunum and ileum), such as increased GSH levels (except the ileum), decreased MDA levels, indicating a reduction oxidative stress. The probiotics decreased TNF-α and IL-6 levels, neutrophils infiltration, reducing the inflammatory response. The relationship villus / crypt was reversed, demonstrating intestinal mucosal protection. Probiotics did not show a significant reversal of histological scores. The delayed gastric emptying was reversed by Probiatop® but not by Probiotil®. However, there was no effect of probiotics on the intestinal transit changes. In conclusion, Probiotil® and Probiatop® protected the intestinal mucosa from antioxidant and anti-inflammatory activities. However, only Probiatop® reversed gastric emptying.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2021-09-10T12:08:29Z
dc.date.available.fl_str_mv 2021-09-10T12:08:29Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv QUARESMA, Marielle Pires. Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos. 2016. 86 f. Dissertação (Mestrado em Ciências Morfofuncionais ) - Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, 2016.
dc.identifier.uri.fl_str_mv http://www.repositorio.ufc.br/handle/riufc/60372
identifier_str_mv QUARESMA, Marielle Pires. Lactobacillus spp. E Bifidobacterium sp. atenuam a mucosite intestinal experimental induzida por 5-fluorouracil em camundongos. 2016. 86 f. Dissertação (Mestrado em Ciências Morfofuncionais ) - Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, 2016.
url http://www.repositorio.ufc.br/handle/riufc/60372
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal do Ceará (UFC)
instname:Universidade Federal do Ceará (UFC)
instacron:UFC
instname_str Universidade Federal do Ceará (UFC)
instacron_str UFC
institution UFC
reponame_str Repositório Institucional da Universidade Federal do Ceará (UFC)
collection Repositório Institucional da Universidade Federal do Ceará (UFC)
bitstream.url.fl_str_mv http://repositorio.ufc.br/bitstream/riufc/60372/2/license.txt
http://repositorio.ufc.br/bitstream/riufc/60372/1/2016_dis_mpquaresma.pdf
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
92b5a033489cdddbeb4809932bdf1a83
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)
repository.mail.fl_str_mv bu@ufc.br || repositorio@ufc.br
_version_ 1847793060896833536